SEC Form 4 · accession 0001209191-18-054716

GENOMIC HEALTH INC · GHDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

James J Vaughn

Officer — Chief Commercial Officer

Period of report

Oct 8, 2018

Accepted (ET)

Oct 10, 2018 · 6:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001131324

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Oct 8, 2018	M	3,732	$28.05	A	21,274	D
Common Stock^F1	Oct 8, 2018	M	18,110	$30.84	A	39,384	D
Common Stock^F1	Oct 8, 2018	M	2,838	$31.12	A	42,222	D
Common Stock^F1	Oct 8, 2018	M	320	$27.00	A	42,542	D
Common Stock^F2,F3,F4,F1	Oct 8, 2018	S	16,215	$64.976	D	26,327	D
Common Stock^F2,F3,F5,F1	Oct 8, 2018	S	6,310	$65.8155	D	20,017	D
Common Stock^F2,F3,F6,F1	Oct 8, 2018	S	2,475	$66.5197	D	17,542	D
Common Stock^F1	Oct 9, 2018	M	5,653	$27.48	A	23,195	D
Common Stock^F1	Oct 9, 2018	M	2,390	$31.12	A	25,585	D
Common Stock^F1	Oct 9, 2018	M	16,957	$27.00	A	42,542	D
Common Stock^F2,F3,F7,F1	Oct 9, 2018	S	19,270	$64.2293	D	23,272	D
Common Stock^F2,F3,F8,F1	Oct 9, 2018	S	5,730	$64.8563	D	17,542	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F9	$28.05	Oct 8, 2018	M	3,732	D	—	Jan 31, 2023	Common Stock	3,732	0	D
Employee Stock Option (right to buy)^F10	$30.84	Oct 8, 2018	M	18,110	D	—	Jan 28, 2024	Common Stock	18,110	0	D
Employee Stock Option (right to buy) Holding^F11	$31.12	Oct 8, 2018	M	2,838	D	—	Feb 13, 2025	Common Stock	2,838	42,162	D
Employee Stock Option (right to buy) Holding^F11	$31.12	Oct 9, 2018	M	2,390	D	—	Feb 13, 2025	Common Stock	2,390	39,772	D
Employee Stock Option (right to buy) Holding^F12	$27.00	Oct 8, 2018	M	320	D	—	Feb 16, 2026	Common Stock	320	41,380	D
Employee Stock Option (right to buy) Holding^F12	$27.00	Oct 9, 2018	M	16,957	D	—	Feb 16, 2026	Common Stock	16,957	24,423	D
Employee Stock Option (right to buy) Holding^F13	$27.48	Oct 9, 2018	M	5,653	D	—	Jan 31, 2027	Common Stock	5,653	34,927	D

Explanation of responses

F1Includes an aggregate of 15,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F10The option became exercisable as to 25% of the shares on January 28, 2015, and became exercisable as to 1/48th of the shares each full month thereafter.
F11The option becomes exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter.
F12The option became exercisable as to 25% of the shares on February 16, 2017, and becomes exercisable as to 1/48th of the shares each full month thereafter.
F13The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.
F2These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 6, 2018.
F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
F4Represents weighted average sale price. Actual sale prices ranged from $64.37 to $65.34.
F5Represents weighted average sale price. Actual sale prices ranged from $65.37 to $66.36.
F6Represents weighted average sale price. Actual sale prices ranged from $66.37 to $66.76.
F7Represents weighted average sale price. Actual sale prices ranged from $63.57 to $64.56.
F8Represents weighted average sale price. Actual sale prices ranged from $64.57 to $65.27.
F9The option became exercisable as to 25% of the shares on January 31, 2014, and became exercisable as to 1/48th of the shares each full month thereafter.